Moderna Inc (NASDAQ:MRNA)

79.82
Delayed Data
As of Dec 01
 +2.12 / +2.73%
Today’s Change
62.55
Today|||52-Week Range
217.25
-55.56%
Year-to-Date
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Nov 29 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Could Be Millionaire Makers
Nov 22 / MotleyFool.com - Paid Partner Content
Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up
Nov 28 / Zacks.com - Paid Partner Content
Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year
Nov 21 / Zacks.com - Paid Partner Content
Moderna (MRNA): A Fair Valuation in Today's Market?
Nov 28 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close77.70
Today’s open76.50
Day’s range74.52 - 80.26
Volume235,583
Average volume (3 months)4,125,957
Market cap$30.4B
Data as of 4:00pm ET, 12/01/2023

Growth & Valuation

Earnings growth (last year)-29.90%
Earnings growth (this year)-112.01%
Earnings growth (next 5 years)-51.00%
Revenue growth (last year)+3.78%
P/E ratioNM
Price/Sales3.91
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+0.53+0.23%
----
BMRNBiomarin Pharmaceuti...+1.37+1.50%
ILMNIllumina Inc+7.85+7.70%
Data as of 4:00pm ET, 12/01/2023

Financials

Next reporting dateFebruary 22, 2024
EPS forecast (this quarter)$0.97
Annual revenue (last year)$19.1B
Annual profit (last year)$8.4B
Net profit margin43.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts